Mail

UK markets closed

FTSE 100
8,237.72
-34.74(-0.42%)
FTSE 250
20,442.35
-56.37(-0.27%)
AIM
772.57
+0.19(+0.02%)
GBP/EUR
1.1822
+0.0000(+0.00%)
GBP/USD
1.2650
-0.0010(-0.08%)
Bitcoin GBP
50,919.68
+125.57(+0.25%)

Homes with impressive sports facilities

Properties with tennis and basketball courts to pools and even a football pitch at the doorstep

Beijing Chunlizhengda Medical Instruments Co., Ltd. (688236.SS)

Shanghai - Shanghai Delayed price. Currency in CNY

Add to watchlist

15.03

-0.04

(-0.27%)

At close: 03:00PM CST

Currency in CNY

Valuation measures⁴

Market cap (intra-day)	5.16B
Enterprise value	3.06B
Trailing P/E	20.88
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	4.80
Price/book (mrq)	2.00
Enterprise value/revenue	2.54
Enterprise value/EBITDA	8.99

Trading information

Stock price history

Beta (5Y monthly)	-0.79
52-week change ³	-41.99%
S&P500 52-week change ³	26.24%
52-week high ³	30.77
52-week low ³	14.73
50-day moving average ³	19.45
200-day moving average ³	22.65

Share statistics

Avg vol (3-month) ³	2.15M
Avg vol (10-day) ³	2.05M
Shares outstanding ⁵	288.43M
Implied shares outstanding ⁶	330.92M
Float ⁸	156.85M
% held by insiders ¹	75.25%
% held by institutions ¹	18.19%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.31
Forward annual dividend yield ⁴	2.08%
Trailing annual dividend rate ³	0.36
Trailing annual dividend yield ³	2.40%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	43.47%
Dividend date ³	N/A
Ex-dividend date ⁴	28 Jul 2023
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	23.40%
Operating margin (ttm)	24.16%

Management effectiveness

Return on assets (ttm)	4.55%
Return on equity (ttm)	9.70%

Income statement

Revenue (ttm)	1.18B
Revenue per share (ttm)	3.03
Quarterly revenue growth (yoy)	-9.90%
Gross profit (ttm)	N/A
EBITDA	286.12M
Net income avi to common (ttm)	277.07M
Diluted EPS (ttm)	0.72
Quarterly earnings growth (yoy)	-1.40%

Balance sheet

Total cash (mrq)	1.96B
Total cash per share (mrq)	5.11
Total debt (mrq)	1.77M
Total debt/equity (mrq)	0.06%
Current ratio (mrq)	5.63
Book value per share (mrq)	7.65

Cash flow statement

Operating cash flow (ttm)	502.3M
Levered free cash flow (ttm)	346.65M